Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Background: Moderate and high efficacy disease modifying therapies (DMTs) have a profound effect on disease activity. The current treatment guidelines only recommend high efficacy DMTs for patients with highly active MS. The objective was to examine the impact of initial treatment choice in achievin...

Descripción completa

Detalles Bibliográficos
Autores principales: Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248666/
https://www.ncbi.nlm.nih.gov/pubmed/34220694
http://dx.doi.org/10.3389/fneur.2021.693017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248666/
https://www.ncbi.nlm.nih.gov/pubmed/34220694
http://dx.doi.org/10.3389/fneur.2021.693017

Ejemplares similares